
Lisata Therapeutics Inc.
LSTA · NASDAQ · Healthcare / Biotechnology
Price History
Full chartMarket Stats
About
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens. Lisata Therapeutics, Inc. was formerly known as Caladrius Biosciences, Inc. and changed its name to Lisata Therapeutics, Inc. in September 2022. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
Company Details
- SectorHealthcare
- IndustryBiotechnology
- CEODr. David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D.
- Employees21
- Headquarters110 Allen Road, Basking Ridge, NJ, United States, 07920, USA
- Websitehttps://www.lisata.com
Leadership
- Dr. David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D.President, CEO & Director · b. 1957
- Mr. James NiscoSenior VP of Finance, Treasurer, CAO & Principal Financial and Accounting Officer · b. 1971
- Mr. Tariq ImamHead of Human Resources, Senior VP of Business Development & Operations and General Counsel · b. 1983
Financials
Income Statement
Balance Sheet
Cash Flow
Earnings
Key Statistics & Ratios
Analyst Ratings
- Strong Buy1
- Buy2
Ownership Breakdown
- Institutions
- 13.41%
- Insiders
- 21.88%
- Retail / Other
- 64.71%
Top Institutional Holders
- Vanguard Capital Management, LLC271.81K3.02%
- Renaissance Technologies Corp131.72K1.46%
- Deltec Asset Management LLC83.20K0.92%
- Geode Capital Management, LLC70.89K0.79%
- Css LLC61.90K0.69%
- BlackRock Inc54.86K0.61%
- Virtu Financial LLC42.21K0.47%
- Vanguard Fiduciary Trust Co34.92K0.39%
- State Street Corp25.35K0.28%
- Citadel Advisors Llc15.54K0.17%
- JBF Capital, Inc.13.23K0.15%
- HPM Partners LLC12.18K0.14%
- SOL Capital Management Co12.18K0.14%
- Susquehanna International Group, LLP11.60K0.13%
- Bank of America Corp10.35K0.11%
- Northern Trust Corp10.27K0.11%
- HighTower Advisors, LLC10.04K0.11%
Top Fund Holders
- Vanguard MStar Total Stk Mkt Idx Invest191.37K2.17%
- Fidelity Extended Market Index38.27K0.43%
- Fidelity Series Total Market Index10.37K0.12%
Dividends
Stock Splits
- Sep 15, 20221:15
- Jul 28, 20161:10
- Jul 16, 20131:10
- Aug 9, 20071:10
- Aug 31, 20061:10